A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi sensu lato. There is limited information available about the use of OspA vaccines in this population. In this study, a randomized double-bli...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Vaccine Immunol
Autors principals: Wressnigg, Nina, Barrett, P. Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G., Crowe, Brian A., Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G., Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F. K., Aichinger, Gerald
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248771/
https://ncbi.nlm.nih.gov/pubmed/25185574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00406-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars